2 withdrawn, 1 completed, 1 terminated. 2 Phase 1, 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
Follow Dynacure: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies DYN101 - Centronuclear Myopathy | Phase 1 / Phase 2 | Withdrawn | Dynacure | 2024-01-01 | 2022-07-11 | |
| Natural History Study of Patients With Centronuclear Myopathies Centronuclear Myopathy | Withdrawn | Dynacure | 2022-09-01 | 2022-07-11 | ||
| Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies DYN101 - Centronuclear Myopathy | Phase 1 / Phase 2 | Terminated | Dynacure | 14 | 2020-01-09 | 2023-06-27 |
| Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies Standardized strength, respiratory and motor function assessments - Centronuclear Myopathy | Not applicable | Completed | Institut de Myologie, France | 60 | 2017-05-28 | 2023-03-02 |
Myopathies, Structural, Congenital (4) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2)
Respiratory Rate (1)
France (3) · Germany (3) · Belgium (2) · Denmark (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1)
Chris Freitag, MD (1) · Laurent Servais, MD (1) · N.C. Voermans, MD, PhD (1)